Neuphoria Therapeutics (NEUP) Shares Outstanding (Diluted) (2020 - 2026)
Neuphoria Therapeutics (NEUP) reported Shares Outstanding (Diluted) of 124.66 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), unchanged from 124.66 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
Dating back to fiscal Q4 2020, Neuphoria Therapeutics' Shares Outstanding (Diluted) record includes 16 quarters.
- Shares Outstanding (Diluted) has a five-year compound annual growth rate of 13.9% (FY2021 to FY2026).
- By fiscal year, Shares Outstanding (Diluted) came in at 124.66 million in FY2025 (unchanged), 124.66 million in FY2024 (+1.9%), 122.39 million in FY2023 (+8.5%) and 112.77 million in FY2022 (+73.5%).
- Over the past five years, the year-over-year growth in Shares Outstanding (Diluted) ranged from 0.0% (fiscal Q1 2025) to 73.5% (fiscal Q4 2022).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at 124.66 million (Q3 2026), 124.66 million (Q2 2026) and 124.66 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Neuphoria Therapeutics | 443.79 Mn | 368.60 Mn | - | 124.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 124.66 Mn |
| Mar 31, 2026 | 124.66 Mn |
| Dec 31, 2025 | 124.66 Mn |
| Sep 30, 2025 | 124.66 Mn |
| Jun 30, 2025 | 124.66 Mn |
| Mar 31, 2025 | 124.66 Mn |
| Dec 31, 2024 | 124.66 Mn |
| Sep 30, 2024 | 124.66 Mn |
| Jun 30, 2024 | 124.66 Mn |
| Mar 31, 2024 | 124.66 Mn |
| Dec 31, 2023 | 124.66 Mn |
| Sep 30, 2023 | 124.66 Mn |
| Jun 30, 2023 | 122.39 Mn |
| Jun 30, 2022 | 112.77 Mn |
| Jun 30, 2021 | 64.99 Mn |
| Jun 30, 2020 | 45.40 Mn |
API Access
Neuphoria Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();